UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 949

Sortiert nach

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine

Science (American Association for the Advancement of Science), 2017-08, Vol.357 (6350), p.503-507

2017

Volltextzugriff (PDF)

Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet

Physiology & behavior, 2017-07, Vol.176, p.139-148

2017

Volltextzugriff (PDF)

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

Drug and alcohol dependence, 2014-11, Vol.144, p.12-41

2014

Volltextzugriff (PDF)

Bath salts and synthetic cathinones: An emerging designer drug phenomenon

Life sciences (1973), 2014-02, Vol.97 (1), p.2-8

2014

Volltextzugriff (PDF)

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products

Neuropsychopharmacology (New York, N.Y.), 2013-03, Vol.38 (4), p.552-562

2013

Volltextzugriff (PDF)

Designer drugs: mechanism of action and adverse effects

Archives of toxicology, 2020-04, Vol.94 (4), p.1085-1133

2020

Volltextzugriff (PDF)

Pharmacological characterization of designer cathinones in vitro

British journal of pharmacology, 2013-01, Vol.168 (2), p.458-470

2013

Volltextzugriff (PDF)

Psychedelic-inspired drug discovery using an engineered biosensor

Cell, 2021-05, Vol.184 (10), p.2779-2792.e18

2021

Volltextzugriff (PDF)

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Life sciences (1973), 2014-02, Vol.97 (1), p.45

2014

Volltextzugriff (PDF)

Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues

Psychopharmacologia, 2011-04, Vol.214 (3), p.593-602

2011

Volltextzugriff (PDF)

Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV)

Neuropharmacology, 2014-12, Vol.87, p.206-213

2014

Volltextzugriff (PDF)

Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food”

Toxicology letters, 2012-06, Vol.211 (2), p.144-149

2012

Volltextzugriff (PDF)

Spicing things up: synthetic cannabinoids

Psychopharmacology, 2013-08, Vol.228 (4), p.525-540

2013

Volltextzugriff (PDF)

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

Progress in neuro-psychopharmacology & biological psychiatry, 2012-12, Vol.39 (2), p.234-243

2012

Volltextzugriff (PDF)

Focus on cannabinoids and synthetic cannabinoids

Clinical pharmacology and therapeutics, 2017-02, Vol.101 (2), p.220-229

2017

Volltextzugriff (PDF)

Baths salts, spice, and related designer drugs: the science behind the headlines

The Journal of neuroscience, 2014-11, Vol.34 (46), p.15150-15158

2014

Volltextzugriff (PDF)

Khat and synthetic cathinones: a review

Archives of toxicology, 2014, Vol.88 (1), p.15-45

2014

Volltextzugriff (PDF)

Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids

Life sciences (1973), 2014-02, Vol.97 (1), p.55-63

2014

Volltextzugriff (PDF)

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

ACS chemical neuroscience, 2015-09, Vol.6 (9), p.1546-1559

2015

Volltextzugriff (PDF)

Monoamine transporter and receptor interaction profiles of a new series of designer cathinones

Neuropharmacology, 2014-04, Vol.79, p.152-160

2014

Volltextzugriff (PDF)

Designer broad-spectrum polyimidazolium antibiotics

Proceedings of the National Academy of Sciences - PNAS, 2020-12, Vol.117 (49), p.31376-31385

2020

Volltextzugriff (PDF)

Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports

Drug and alcohol dependence, 2013-09, Vol.132 (1), p.1-12

2013

Volltextzugriff (PDF)

Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling

Swiss medical weekly, 2015-01, Vol.145, p.w14043

Liechti, Matthias

2015

Volltextzugriff (PDF)

Stereoselective Effects of Abused "Bath Salt" Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation

The Journal of pharmacology and experimental therapeutics, 2016-03, Vol.356 (3), p.615

2016

Volltextzugriff (PDF)

1 – 25 von 949

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(808)
Mit Volltextzugriff
(783)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

7 weitere anzeigen...

Weniger anzeigen...

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(1)

Menü

Weitere Dienste

Einstellungen

Chemogenetics revealed: DREADD occupancy and activation via converted clozapine

Orexin activation counteracts decreases in nonexercise activity thermogenesis (NEAT) caused by high-fat diet

Synthetic cannabinoids: Epidemiology, pharmacodynamics, and clinical implications

Bath salts and synthetic cathinones: An emerging designer drug phenomenon

Powerful Cocaine-Like Actions of 3,4-Methylenedioxypyrovalerone (MDPV), a Principal Constituent of Psychoactive 'Bath Salts' Products

Designer drugs: mechanism of action and adverse effects

Pharmacological characterization of designer cathinones in vitro

Psychedelic-inspired drug discovery using an engineered biosensor

Distinct pharmacology and metabolism of K2 synthetic cannabinoids compared to Δ(9)-THC: mechanism underlying greater toxicity?

Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues

Pharmacology of novel synthetic stimulants structurally related to the “bath salts” constituent 3,4-methylenedioxypyrovalerone (MDPV)

Synthetic cathinones: Chemistry, pharmacology and toxicology of a new class of designer drugs of abuse marketed as “bath salts” or “plant food”

Spicing things up: synthetic cannabinoids

Spice drugs are more than harmless herbal blends: A review of the pharmacology and toxicology of synthetic cannabinoids

Deschloroclozapine, a potent and selective chemogenetic actuator enables rapid neuronal and behavioral modulations in mice and monkeys

Focus on cannabinoids and synthetic cannabinoids

Baths salts, spice, and related designer drugs: the science behind the headlines

Khat and synthetic cathinones: a review

Moving around the molecule: Relationship between chemical structure and in vivo activity of synthetic cannabinoids

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

Monoamine transporter and receptor interaction profiles of a new series of designer cathinones

Designer broad-spectrum polyimidazolium antibiotics

Clinical and pharmacological aspects of bath salt use: A review of the literature and case reports

Novel psychoactive substances (designer drugs): overview and pharmacology of modulators of monoamine signaling

Stereoselective Effects of Abused "Bath Salt" Constituent 3,4-Methylenedioxypyrovalerone in Mice: Drug Discrimination, Locomotor Activity, and Thermoregulation

Suchergebnisse filtern